Omega Healthcare Investors (OHI) Q3 2025 earnings summary

Executive summary

• Net income for Q3 2025 was $185 million ($0.59 per share), up from $112–$115 million ($0.42 per share) in Q3 2024, with nine-month net income rising to $437.50 million from $301.34 million year-over-year.

• Strong revenue and EBITDA growth were driven by acquisitions, active portfolio management, and nearly $1 billion in new investments year-to-date.

• Major investments included $637.9 million in facility acquisitions, $85.7 million in construction/capital improvements, and a 49% JV with Saber for $222 million.

• Strategic capital allocation focused on expanding investment structures, selective joint ventures, and innovative deal structures to enhance shareholder value.

• Portfolio occupancy and EBITDA coverage reached multi-year highs, with further improvement expected.

Financial highlights

• Q3 2025 revenue was $312 million, up from $276 million in Q3 2024; nine-month revenues reached $870.88 million, up from $772.07 million year-over-year.

• Adjusted FFO for Q3 2025 was $243 million ($0.79/share); FAD was $231 million ($0.75/share), both up year-over-year.

• Dividend payout ratios dropped to 85% for AFFO and 89% for FAD; quarterly dividend was $0.67 per share.

• Cash and cash equivalents totaled $737–$775 million at quarter-end, with $2.3 billion in undrawn credit capacity.

• Total assets were $10.60 billion and total equity was $5.24 billion as of September 30, 2025.

Outlook and guidance

• 2025 AFFO guidance raised to $3.08–$3.10 per share, up $0.035 from prior midpoint, reflecting strong investment activity and JV formation.

• Guidance assumes no additional investments or asset sales beyond those completed by October 30th, and continued rent payments from Genesis and Maplewood.

• G&A expense for Q4 projected at $13.5–$14.5 million.

• Management remains cautious due to ongoing industry challenges, including staffing shortages, inflation, and regulatory uncertainty.

• Sufficient liquidity is expected to fund operations, dividends, and investments over the next twelve months.